Spojené státy - angličtina - NLM (National Library of Medicine)

kmm pharmaceuticals, llc - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide gel, 0.05% is indicated for the treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. patients should be instructed to use desonide gel, 0.05% for the minimum amount of time as necessary to achieve the desired results because of the potential for desonide gel, 0.05% to suppress the hypothalamicpituitary-adrenal (hpa) axis [see warnings and precautions ( 5.1)]. treatment should not exceed 4 consecutive weeks [see dosage and administration ( 2)]. desonide gel, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. teratogenic effects: pregnancy category c: there are no adequate and well-controlled studies in pregnant women. therefore, desonide gel, 0.05% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. some

Spojené státy - angličtina - NLM (National Library of Medicine)

actavis mid atlantic llc - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g

Spojené státy - angličtina - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. it should not be used for longer than two weeks unless directed by a physician. desonide cream, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

glenmark pharmaceuticals inc., usa - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. it should not be used for longer than two weeks unless directed by a physician. desonide ointment, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide lotion is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. desonide lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide lotion is a low to medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.. desonide lotion is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

american health packaging - budesonide (unii: q3oks62q6x) (budesonide - unii:q3oks62q6x) - budesonide delayed-release capsules (enteric coated) are indicated for the treatment of mild to moderate active crohn's disease involving the ileum and/or the ascending colon in patients 8 years of age and older. budesonide delayed-release capsules (enteric coated) are indicated for the maintenance of clinical remission of mild to moderate crohn's disease involving the ileum and/or the ascending colon for up to 3 months in adults. budesonide capsules (enteric coated) are contraindicated in patients with hypersensitivity to budesonide or any of the ingredients of budesonide capsules (enteric coated). serious hypersensitivity reactions, including anaphylaxis have occurred [see adverse reactions (6.2)]. risk summary limited published studies report on the use of budesonide in pregnant women; however, the data are insufficient to inform a drug-associated risk for major birth defects and miscarriage. there are clinical considerations [see clinical considerations]. in animal re

Spojené státy - angličtina - NLM (National Library of Medicine)

encube ethicals private limited - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide ointment, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. it should not be used for longer than two weeks unless directed by a physician. desonide ointment, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

zydus pharmaceuticals (usa) inc. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. it should not be used for longer than two weeks unless directed by a physician. desonide cream, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Spojené státy - angličtina - NLM (National Library of Medicine)

physicians total care, inc. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g